i10 Productivity
Rankings
Pfizer Inc. ScientistsOthers i10 Productivity Rankings 2024
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
| Total i10 Index | AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 | i10 Index Metrics | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| University Rank | Country Rank | Region Rank | World Rank | Name | Country | University / Institution |
Subject Research Areas |
Total | Last 6 Year | Last 6 year/total |
| 258 | 201,155 | 226,047 | 760,594 |
United States |
Pfizer Inc.
|
Others
|
15 | 7 | 0.467 | |
| 259 | 201,628 | 226,566 | 763,080 |
United States |
Pfizer Inc.
|
Others
|
15 | 4 | 0.267 | |
| 262 | 202,914 | 227,964 | 767,120 |
United States |
Pfizer Inc.
|
Others
Metabolism | Immunology | |
14 | 14 | 1.000 | |
| 268 | 206,054 | 231,404 | 778,747 |
United States |
Pfizer Inc.
|
Others
Biomarkers | translational research | Precision Medicine | Bioanalysis | Immunogenicity | |
14 | 11 | 0.786 | |
| 269 | 206,197 | 231,564 | 779,090 |
United States |
Pfizer Inc.
|
Others
Immunology | |
14 | 11 | 0.786 | |
| 270 | 206,226 | 231,596 | 779,159 |
United States |
Pfizer Inc.
|
Others
Computational Toxicology | ADMET | |
14 | 11 | 0.786 | |
| 272 | 206,896 | 232,328 | 781,847 |
United States |
Pfizer Inc.
|
Others
Drug Discovery | Assay Development | HTS Screening | Membrane Proteins | |
14 | 10 | 0.714 | |
| 274 | 207,101 | 232,555 | 782,350 |
United States |
Pfizer Inc.
|
Others
Tumor Immunology | Infectious Disease Immunology | |
14 | 10 | 0.714 | |
| 275 | 208,418 | 234,021 | 787,925 |
United States |
Pfizer Inc.
|
Others
|
14 | 8 | 0.571 | |
| 278 | 209,002 | 234,662 | 790,588 |
United States |
Pfizer Inc.
|
Others
|
14 | 6 | 0.429 | |
|
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
|
||||||||
| 283 | 211,772 | 237,716 | 801,571 |
United States |
Pfizer Inc.
|
Others
|
13 | 12 | 0.923 | |
| 284 | 212,453 | 238,472 | 803,370 |
United States |
Pfizer Inc.
|
Others
|
13 | 12 | 0.923 | |
| 285 | 212,725 | 238,774 | 804,549 |
United States |
Pfizer Inc.
|
Others
Drug delivery | diabetes | targeted drug delivery | polymeric injectables | |
13 | 12 | 0.923 | |
| 289 | 215,024 | 241,313 | 813,540 |
United States |
Pfizer Inc.
|
Others
|
13 | 9 | 0.692 | |
| 294 | 216,415 | 242,849 | 819,156 |
United States |
Pfizer Inc.
|
Others
|
13 | 7 | 0.538 | |
| 295 | 216,513 | 242,956 | 819,530 |
United States |
Pfizer Inc.
|
Others
Medicine | |
13 | 7 | 0.538 | |
| 296 | 216,620 | 243,073 | 820,171 |
United States |
Pfizer Inc.
|
Others
Avian Diseases | Avian Health | Virology | |
13 | 7 | 0.538 | |
| 298 | 219,627 | 246,360 | 832,234 |
United States |
Pfizer Inc.
|
Others
Drug Delivery | Nanoparticles | Biopharmaceutics | |
12 | 12 | 1.000 | |
| 300 | 219,875 | 246,639 | 833,729 |
United States |
Pfizer Inc.
|
Others
|
12 | 11 | 0.917 | |
| 301 | 220,877 | 247,731 | 836,358 |
United States |
Pfizer Inc.
|
Others
|
12 | 11 | 0.917 | |
| 302 | 222,295 | 249,302 | 841,546 |
United States |
Pfizer Inc.
|
Others
Medical Informatics | Patient Safety | Handoffs | Standards | Biomedical informatics | |
12 | 10 | 0.833 | |
| 311 | 226,160 | 253,558 | 858,549 |
United States |
Pfizer Inc.
|
Others
Molecular Virology | Big Data Analytics | |
12 | 2 | 0.167 | |
| 312 | 226,401 | 253,829 | 859,715 |
United States |
Pfizer Inc.
|
Others
Cancer | Metabolism | Signaling | |
11 | 11 | 1.000 | |
| 313 | 226,539 | 253,976 | 859,978 |
United States |
Pfizer Inc.
|
Others
R&D | |
11 | 11 | 1.000 | |
| 314 | 226,960 | 254,431 | 860,853 |
United States |
Pfizer Inc.
|
Others
Drug Delivery | Immunology | Vaccines | Nanomedicine | |
11 | 11 | 1.000 | |